Tickerplace logo

Tickerplace

Protagenic Therapeutics, Inc. logo

PTIXProtagenic Therapeutics, Inc.

PTIX Stock Price, Valuation & Chart | Protagenic Therapeutics, Inc.

Compare
$1.050-0.14 (-11.76%)

At close · 02 Sept 2026, 07:58 pm

Sector: HealthcareIndustry: BiotechnologyPTIX intrinsic valuePTIX calculated fair value vs price
OverviewFinancialsDividendsRatios

PTIX Historical price chart

PTIX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.90M
PE Ratio-0.21
EPS-5.06
Trading Volume6.70K
Today's High/Low1.2/1.05
Dividend Yield0.00
52 Week High/Low4.55/0.13
Shares Outstanding1.81M
PTIX Financial Statement
PTIX Analyst ratings
PTIX Analysis & performance metrics

PTIX Company profile

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood…

PTIX Management team

Management
Alexander Kenneth Arrow C.F.A., M.D.CFO
Chief Financial Officer & Secretary
Andrew Slee Ph.D.COO
Chief Operating Officer
Garo H. Armen Ph.D.
Co-Founder & Executive Chairman of the Board
Robert Benjamin Stein M.D., Ph.D.CTO
Chief Medical Officer & Director
Total 4 executives

PTIX Frequently asked questions

What is Protagenic Therapeutics, Inc. (PTIX) Stock Price?

Current stock price of Protagenic Therapeutics, Inc. (PTIX) stock is $1.050. The stock price is -11.76% lower in the session. The intraday range can be seen from this page. Volume of Protagenic Therapeutics, Inc. (PTIX) stock is 6.70K.

Last updated at 02 Sept 2026, 07:58 pm.

Why is the Protagenic Therapeutics, Inc. (PTIX) stock price going up or down today?

The stock price of Protagenic Therapeutics, Inc. (PTIX) can change with earnings, company news, and overall market sentiment. Protagenic Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Protagenic Therapeutics, Inc. stock expensive at its current price?

Whether Protagenic Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PTIX on this page is -0.21. EPS on this page is -5.06. Compare those figures with peers and growth expectations before deciding if the current Protagenic Therapeutics, Inc. price is justified.

How has the stock price of Protagenic Therapeutics, Inc. (PTIX) performed historically?

Historical performance for Protagenic Therapeutics, Inc. (PTIX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PTIX reacted to past earnings and market events.

Should I buy Protagenic Therapeutics, Inc. (PTIX) stock, at this price?

Buying Protagenic Therapeutics, Inc. (PTIX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.